The relation of the role of CTRP7 in the development of type 2 diabetes and its possible mechanisms

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400090980

Enrollment

Unknown

Registered

2024-10-17

Start date

2023-07-31

Completion date

Unknown

Last updated

2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus

Interventions

Normal control :None

The group with abnormal glucose tolerance:None

Type 2 diabetes group:None

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) met the World Health Organization (WHO) diagnostic criteria for type 2 diabetes, fasting blood glucose 7.0 ml / L; or 2h postprandial blood glucose 11.1mml/L; or random blood glucose 11.1mml/L; (2) primary diagnosis and no hypoglycemic drugs, insulin, and diet and exercise control therapy.

Exclusion criteria

Exclusion criteria: (1) age 70 years; (2) type 1 diabetes or other types of diabetes; (3) other endocrine diseases, such as type 2 diabetes, thyroid disease, etc; (4) antihypertensive and lipid lowering drugs; (5) severe liver and kidney insufficiency; (6) pregnancy; (7) cardiovascular and cerebrovascular diseases.

Design outcomes

Primary

Measure	Time frame
CTRP7;HDL-C;LDL-C;	—

Secondary

Measure	Time frame
FPG;2hPG;FINS;HbA1c;CTRP6;BMP9;Irisin;ADP;TNF-a;VFA;ALT;AST;TG;TC;OSM;	—

Countries

China

Contacts

Public ContactLin Zhang

Bayannur city Hospital

1374516464@qq.com+86 198 4788 1111

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026